Literature DB >> 21512878

Novel handheld PET probes provide intraoperative localization of PET-avid lymph nodes.

Segundo J González1, Joyce Wong, Lorena González, Peter Brader, Maureen Zakowski, Mithat Gönen, Yuman Fong, Vivian E Strong.   

Abstract

INTRODUCTION: The accurate intraoperative localization of malignant nodes can pose a challenge to the surgical oncologist. Positron emission tomography (PET) scanning has significantly increased our ability to detect suspicious lesions. We investigated the ability of a novel, handheld tool to evaluate suspicious nodes intraoperatively and to correlate its findings with those seen on preoperative PET scan.
METHODS: Ten nude rats were inoculated with a lymphogenic mesothelioma tumor line and followed weekly with PET scan studies. When suspicious lymph nodes were found, animals were dissected and the intraoperative amount of tissue radiation was analyzed as "tumor-to-background ratio" (TBR) using the PET probes.
RESULTS: The intraoperative probe was used to guide dissections and select high-risk nodes based on their specific radiotracer uptake. A total of 52 nodes were harvested; eight of these were suspicious on preoperative PET scan studies. Using a TBR of 2.5, the intraoperative probes were able to localize all suspicious nodes previously seen on PET scan. Both gamma (sensitivity: 100%; specificity: 86%; positive predictive value (PPV): 57%; negative predictive value (NPV): 100%) and beta (sensitivity: 88%; specificity: 91%; PPV: 64%; NPV: 98%) probes showed an excellent area under the curve (AUC) in the receiver operating characteristic analysis (ROC). Both probes had an AUC of 0.95 for localizing suspicious nodes on PET scan. Furthermore, the AUC for detecting malignancy for the gamma probe was 0.90 (95% confidence interval (CI), 0.83-0.99), and for the beta probe it was 0.97 (95% CI, 0.94-1.0), suggesting a better performance of the beta probe for detecting malignancy.
CONCLUSIONS: This novel tool may be used synergistically with the PET scan examination to maximize intraoperative nodal selection and sampling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21512878      PMCID: PMC3269818          DOI: 10.1007/s00464-011-1696-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  17 in total

Review 1.  Clinical role of sentinel-lymph-node biopsy in breast cancer.

Authors:  Mohammed R S Keshtgar; Peter J Ell
Journal:  Lancet Oncol       Date:  2002-02       Impact factor: 41.316

2.  Heterotransplantation of human cancer. I. Irradiated rats.

Authors:  S C SOMMERS; R N CHUTE; S WARREN
Journal:  Cancer Res       Date:  1952-12       Impact factor: 12.701

Review 3.  PET probe-guided surgery.

Authors:  Seza A Gulec
Journal:  J Surg Oncol       Date:  2007-09-15       Impact factor: 3.454

4.  Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.

Authors:  K S Nason; B O Anderson; D R Byrd; L K Dunnwald; J F Eary; D A Mankoff; R Livingston; R A Schmidt; K D Jewell; R S Yeung; R E Moe
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

5.  Irradiated nude rat model for orthotopic human lung cancers.

Authors:  R B Howard; H Chu; B E Zeligman; T Marcell; P A Bunn; T L McLemore; D W Mulvin; M E Cowen; M R Johnston
Journal:  Cancer Res       Date:  1991-06-15       Impact factor: 12.701

6.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.

Authors:  J A van Dongen; H Bartelink; I S Fentiman; T Lerut; F Mignolet; G Olthuis; E van der Schueren; R Sylvester; J Winter; K van Zijl
Journal:  J Natl Cancer Inst Monogr       Date:  1992

7.  Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma.

Authors:  Elisa Rush Port; Jane Fey; Mary L Gemignani; Alexandra S Heerdt; Leslie L Montgomery; Jeanne A Petrek; Virgilio Sacchini; Kimberly J Van Zee; Patrick I Borgen; Hiram S Cody
Journal:  J Am Coll Surg       Date:  2002-08       Impact factor: 6.113

8.  Intraoperative beta probe: a device for detecting tissue labeled with positron or electron emitting isotopes during surgery.

Authors:  F Daghighian; J C Mazziotta; E J Hoffman; P Shenderov; B Eshaghian; S Siegel; M E Phelps
Journal:  Med Phys       Date:  1994-01       Impact factor: 4.071

9.  What is the most appropriate scan timing for intraoperative detection of malignancy using 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study.

Authors:  Tatsuya Higashi; Tsuneo Saga; Takayoshi Ishimori; Marcelo Mamede; Koichi Ishizu; Toru Fujita; Takahiro Mukai; Seiji Sato; Hironori Kato; Yoshio Yamaoka; Keiichi Matsumoto; Michio Senda; Junji Konishi
Journal:  Ann Nucl Med       Date:  2004-04       Impact factor: 2.668

10.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.

Authors:  B Fisher; C Redmond; R Poisson; R Margolese; N Wolmark; L Wickerham; E Fisher; M Deutsch; R Caplan; Y Pilch
Journal:  N Engl J Med       Date:  1989-03-30       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.